XML 16 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net income $ 47,000 $ 159,587
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 96,027 72,413
Amortization of debt issuance costs 2,278 2,034
Equity-based compensation expense 19,226 17,547
Deferred income taxes (8,753) 39,017
Debt extinguishment costs 1,269  
Legal settlements expense 3,504  
Loss on impairment 1,452 1,000
Gain on sale of property (8,715)  
Other 1,128 (3,942)
Change in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable, net (42,660) (26,114)
Other current assets (3,797) (14,182)
Other assets (7,684) 842
Accounts payable and other accrued liabilities 27,684 (399,619)
Accrued salaries and benefits (3,940) (8,525)
Other liabilities 20,962 9,805
Net cash provided by (used in) operating activities 144,981 (150,137)
Investing activities:    
Cash paid for acquisitions, net of cash acquired (8,165) (50,722)
Cash paid for capital expenditures (342,378) (296,652)
Proceeds from sale of property and equipment 16,623 10,209
Other (101) (2,933)
Net cash used in investing activities (334,021) (340,098)
Financing activities:    
Borrowings on long-term debt 1,200,000 350,000
Principal payments on revolving credit facility (1,035,000) (15,000)
Principal payments on long-term debt (4,063) (25,605)
Repayment of long-term debt (670,856)  
Payment of debt issuance costs (18,615) (1,518)
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (3,716) (1,668)
Repurchase of common stock (50,034)  
Contributions from noncontrolling partners in joint ventures   2,970
Distributions to noncontrolling partners in joint ventures (1,990) (1,500)
Cash paid for contingent consideration (1,500)  
Other (70) (350)
Net cash provided by financing activities 244,156 467,329
Net increase (decrease) in cash and cash equivalents 55,116 (22,906)
Cash and cash equivalents at beginning of the period 76,305 100,073
Cash and cash equivalents at end of the period 131,421 77,167
Effect of acquisitions:    
Assets acquired, excluding cash 19,881 55,678
Liabilities assumed (842) (3,456)
Contingent consideration issued in connection with an acquisition   (1,500)
Redeemable noncontrolling interest resulting from an acquisition (10,874)  
Cash paid for acquisitions, net of cash acquired 8,165 50,722
New Credit Facility [Member]    
Financing activities:    
Borrowings on revolving credit facility $ 830,000 $ 160,000